Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon-α2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trial

✍ Scribed by Sergio Bracarda; Joaquim Bellmunt; Bohuslav Melichar; Sylvie Négrier; Emilio Bajetta; Alain Ravaud; Vesna Sneller; Bernard Escudier

• Book ID: 110923222
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 231 KB
• Volume: 107
• Category: Article
• ISSN: 1464-4096
• DOI: 10.1111/j.1464-410x.2010.09707.x